Crossmark

MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination

Crossref DOI link: https://doi.org/10.1136/jitc-2020-001388

Published Online: 2021-03-23

Published Print: 2021-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Wu, Xiaofang https://orcid.org/0000-0002-3782-7701
Nelson, Marie

Basu, Mousumi

Srinivasan, Priya

Lazarski, Christopher

Zhang, Peng

Zheng, Pan

Sandler, Anthony David https://orcid.org/0000-0001-9440-2964
Funding

Funding for this research was provided by:

The EVAN Foundation

Catherine Blair Foundation

Michael Sandler Research Fund (None)
License Information

License valid from 2021-03-22

Document is current

Any future updates will be listed below